DCM
SCPH

Driehaus Capital Management’s scPharmaceuticals SCPH Stock Holding History

Driehaus Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-737,467
Closed -$5.49M – 457
2020
Q3 		$5.49M Sell
737,467
-10,522
-1% -$82.2K 0.11% 191
2020
Q2 		$5.5M Buy
+747,989
New +$6.57M 0.13% 179

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Driehaus Capital Management's SCPH Position: Q4 2020 in Review

Driehaus Capital Management sold out of scPharmaceuticals (SCPH) in Q4 2020, closing a stake of 737,467 shares — an estimated $5.49M sold.

Driehaus Capital Management first reported a position in SCPH in Q2 2020 and held it in 2 quarters. The position peaked at $5.5M in Q2 2020. 47 funds tracked by Wall St. Rank hold SCPH as of Q4 2020.

  • Driehaus Capital Management reported no remaining scPharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Driehaus Capital Management sold 737,467 scPharmaceuticals shares in Q4 2020, an estimated $5.49M.
  • Driehaus Capital Management first reported a position in scPharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Driehaus Capital Management's scPharmaceuticals position peaked at $5.5M in Q2 2020.
  • 47 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2020.

Based on Driehaus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.